A phase 2 clinical trial of luspatercept in non-transfusion-dependent patients with myelodysplastic syndromes.
Kosugi H, Fujisaki T, Iwasaki H, Shinagawa A, Iida H, Jo T, Kubonishi S, Morita Y, Nakashima Y, Onodera K, Suzuki K, Suzuki T, Tamai Y, Usuki K, Yokota A, Yonaga H, Hayakawa J, Midorikawa S, Nishio M, Suda M, Matsue K.
Kosugi H, et al. Among authors: fujisaki t.
Int J Hematol. 2025 Jan;121(1):68-78. doi: 10.1007/s12185-024-03872-3. Epub 2024 Nov 21.
Int J Hematol. 2025.
PMID: 39572468
Clinical Trial.